In order to optimise the impact and re-use of publicly funded scientific research, H2020 programs require exclusively open access publications. The benefits of such an approach are extensive, including better and more efficient science, economic growth, and broader, faster, more transparent and equal access for the benefit of researchers, industry and citizens in the EU and beyond. For more details, take a look at the Open Access Policies and Requirements in Horizon 2020.


Review article: by Simona Del Giudice, Valentina De Luca, Seyedehnegar Parizadeh, Domenico Russo, Alberto Luini and Rosaria Di Martino,

Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer” in Frontiers in Cell and Developmental Biology  2022,  10:833663

doi: 10.3389/fcell.2022.833663


Review article: by Jessica Karta, Ysaline Bossicard, Konstantinos Kotzamanis, Helmut Dolznig  and Elisabeth Letellier, Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts” in the Special Issue Targeting Tumour Metabolism for Cancer Therapy in Cells 202110(2), 304

Ghannoum, S., Leoncio Netto, W., Fantini, D., Ragan-Kelley, B., Parizadeh, A., Jonasson, E., Ståhlberg, A., Farhan, H., & Köhn-Luque, A. (2021). DIscBIO: A User-Friendly Pipeline for Biomarker Discovery in Single-Cell TranscriptomicsInternational journal of molecular sciences22(3), 1399.

Research article: Signorini, L.F., Almozlino, T. & Sharan, R. ANAT 3.0: a framework for elucidating functional protein subnetworks using graph-theoretic and machine learning approaches” in BMC Bioinformatics 22, 526 (2021).



Review article: Monilola A. Olayioye, Bettina Noll and Angelika Hausser, Spatiotemporal control of intracellular membrane trafficking by Rho GTPases” in the Special Issue “Membrane Traffic in Health and Disease” in Cells 20198(12), 1478;